-

LIVE NATION UPDATE: Rosen Law Firm Provides Live Nation Entertainment, Inc. Investors Update in Securities Class Action – LYV

NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, provides this update to purchasers of Live Nation Entertainment, Inc. (NYSE: LYV) securities in regard to the pending securities class action seeking recovery of investor losses. The suit alleges that Live Nation and certain of its officers and directors issued materially false and misleading statements to investors arising from Live Nation’s improper anticompetitive conduct.

On October 18, 2023, the United States District Court for the Central District of California appointed The Rosen Law Firm as Co-Lead Counsel in this securities class action. On February 23, 2024, the Court denied the defendants’ motion to dismiss. The case is currently in the discovery phase.

If you require additional information or want to join the Live Nation class action, go to https://rosenlegal.com/submit-form/?case_id=18184 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email case@rosenlegal.com for information on the class action. A class action lawsuit has already been filed.

If you purchased Live Nation securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contacts

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
case@rosenlegal.com
www.rosenlegal.com

The Rosen Law Firm, P.A.

NYSE:LYV

Release Versions

Contacts

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
case@rosenlegal.com
www.rosenlegal.com

More News From The Rosen Law Firm, P.A.

Rosen Law Firm Urges Vistagen Therapeutics, Inc. (NASDAQ: VTGN) Stockholders with Large Losses to Contact the Firm for Information About Their Rights

NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of Vistagen Therapeutics, Inc. (NASDAQ: VTGN) common stock between April 1, 2024 and December 16, 2025, both dates inclusive (the “Class Period”). Vistagen is a clinical-stage biopharmaceutical company. For more information, submit a form, email attorney Phillip Kim, or give us a call at 866-767-3653. The Allegations: Rosen Law Firm is Investigating the Allegati...

PRGO Deadline: Rosen Law Firm Urges Perrigo Company plc (NYSE: PRGO) Investors to Contact the Firm for Information About Their Rights

NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, reminds investors that a class action lawsuit on behalf of purchasers of securities of Perrigo Company plc (NYSE: PRGO) between February 27, 2023 and November 4, 2025. Perrigo provides over-the-counter health and wellness solutions. For more information, submit a form, email attorney Phillip Kim, or give us a call at 866-767-3653. The Allegations: Rosen Law Firm is Investigating the Allegations that Perrigo Company pl...

Rosen Law Firm Encourages Phoenix Education Partners, Inc. Investors to Inquire About Securities Class Action Investigation – PXED

NEW YORK--(BUSINESS WIRE)--Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Phoenix Education Partners, Inc. (NYSE: PXED) resulting from allegations that Phoenix Education may have issued materially misleading business information to the investing public. So What: If you purchased Phoenix Education securities you may be entitled to compensation without payment of any out of pocket fees or costs through...
Back to Newsroom